Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Ixchelsis reports positive phase IIa results for IX-01 as treatment of premature ejaculation

Jan. 26, 2016

Hybrid Medical's gel H-100 evaluated in patients with Peyronie's disease

Jan. 20, 2016

FDA accepts IND application for Tricida's TRC-101

Jan. 14, 2016

GTx initiates phase II trial of enobosarm for stress urinary incontinence

Jan. 14, 2016

Medifocus engages Kapec Design Group as lead designer of next generation of Prolieve

Jan. 14, 2016

Ardelyx reports data for RDX-022 in the treatment of hyperkalemia

Jan. 7, 2016

Lundbeck reports PDE9 inhibitors

Dec. 28, 2015

Astellas Pharma patents muscarinic M3 receptor PAMs

Dec. 24, 2015

Astellas Pharma and Kotobuki Pharmaceutical present IRAP and P-LAP inhibitors

Dec. 22, 2015

DMX-200 drug combination given FDA orphan designation for focal segmental glomerulosclerosis

Dec. 15, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...